Oramed Pharmaceuticals Relocates HQ, Updates Contact Info

Ticker: ORMP · Form: 8-K · Filed: May 21, 2025 · CIK: 1176309

Oramed Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyOramed Pharmaceuticals Inc. (ORMP)
Form Type8-K
Filed DateMay 21, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, filing

TL;DR

Oramed Pharma moved its HQ to NYC, new number is 844-967-2633.

AI Summary

On May 21, 2025, Oramed Pharmaceuticals Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 1185 Avenue of the Americas, Third Floor, New York, NY 10036. The company's telephone number has also been updated to 844-967-2633.

Why It Matters

This filing signals a physical relocation for Oramed Pharmaceuticals, potentially impacting operational logistics and accessibility for stakeholders.

Risk Assessment

Risk Level: low — The filing is administrative, reporting a change of address and phone number, which carries minimal inherent risk.

Key Players & Entities

  • Oramed Pharmaceuticals Inc. (company) — Registrant
  • 1185 Avenue of the Americas, Third Floor, New York, NY 10036 (location) — New Principal Executive Offices
  • 844-967-2633 (phone_number) — New Registrant's telephone number
  • May 21, 2025 (date) — Date of report

FAQ

What is the new address for Oramed Pharmaceuticals Inc.'s principal executive offices?

The new address for Oramed Pharmaceuticals Inc.'s principal executive offices is 1185 Avenue of the Americas, Third Floor, New York, New York 10036.

What is the new telephone number for Oramed Pharmaceuticals Inc.?

The new telephone number for Oramed Pharmaceuticals Inc. is 844-967-2633.

On what date was this 8-K report filed?

This 8-K report was filed on May 21, 2025.

What is the Commission File Number for Oramed Pharmaceuticals Inc.?

The Commission File Number for Oramed Pharmaceuticals Inc. is 001-35813.

What is the IRS Employer Identification Number for Oramed Pharmaceuticals Inc.?

The IRS Employer Identification Number for Oramed Pharmaceuticals Inc. is 98-0376008.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding ORAMED PHARMACEUTICALS INC. (ORMP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.